1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, October 2016 (p2)

Biological Therapy Analysis & Statistics, October 2016 (p2)

24/7 Customer Support

Talk to Veronica

+44 207 0971 241

Publishers

31-60 of about 1100 reports

Purchase Reports From Reputable Market Research Publishers

Global Allergy Immunotherapy Market Analysis & Trends - Product Type(Sublingual immunotherapy drops, Subcutaneous immunotherapy and Sublingual immunotherapy tablets), Application - Forecast to 2025

Global Allergy Immunotherapy Market Analysis & Trends - Product Type(Sublingual immunotherapy drops, Subcutaneous immunotherapy and Sublingual immunotherapy tablets), Application - Forecast to 2025

  • € 3818
  • Industry report
  • October 2016
  • by Accuray Research LLP

The Global Allergy Immunotherapy Market is poised to grow at a CAGR of around 8.2% from 2015 to 2025. Some of the prominent trends that the market is witnessing include unmet need for healthcare in developing ...

  • Industries : Biological Therapy
  • Countries : United States
Global Stem Cell Assay Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

Global Stem Cell Assay Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

  • € 3545
  • Industry report
  • November 2016
  • by Occams

The global market of stem cell assay is anticipated to reach USD 1,367.3 Million by 2022 at a CAGR of 21.5% during 2016 to 2022. Due to Rising Investment in Research Related Activities, Funding for Stem ...

  • Industries : Biological Therapy
  • Countries : World
Global 3D Cell Culture Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

Global 3D Cell Culture Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

  • € 3545
  • Industry report
  • November 2016
  • by Occams

"Global 3D Cell Culture Market Research Report 2016" by OBRC, is an extensive study on present state of the 3D Cell Culture Market. 3D cell culture allows culturing of cells in a 3D environment. Adoption ...

  • Industries : Biological Therapy
  • Countries : World
Global Cell Expansion Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

Global Cell Expansion Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

  • € 3545
  • Industry report
  • November 2016
  • by Occams

The global Cell Expansion market is estimated to grow at CAGR of 18.1% during 2016-2022. The Cell Expansion is segmented on the basis of application, cell type, product, end user and geography. The application ...

  • Industries : Biological Therapy
  • Countries : World
Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Pipeline Review, H2 2016

Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Pipeline Review, H2 2016

  • € 3182
  • Company report
  • October 2016
  • by Global Markets Direct

Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) ...

  • Industries : Pathology, Biological Therapy, Therapy, Biotechnology, Chronic Disease
  • Countries : United States, World
C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H2 2016

C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H2 2016

  • € 3182
  • Company report
  • October 2016
  • by Global Markets Direct

C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ...

  • Industries : Therapy, Biological Therapy, Pathology
  • Countries : United States
C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) - Pipeline Review, H2 2016

C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) - Pipeline Review, H2 2016

  • € 3182
  • Company report
  • September 2016
  • by Global Markets Direct

C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) - Pipeline Review, H2 2016’, ...

  • Industries : Biological Therapy, Cancer, Therapy, Pathology, Pharmaceutical
  • Countries : Japan, United States, World
C-X-C Chemokine Receptor Type 1 (CDw128a or High Affinity Interleukin 8 Receptor A or IL8 Receptor Type 1 or CD181 or CXCR1) - Pipeline Review, H2 2016

C-X-C Chemokine Receptor Type 1 (CDw128a or High Affinity Interleukin 8 Receptor A or IL8 Receptor Type 1 or CD181 or CXCR1) - Pipeline Review, H2 2016

  • € 3182
  • Company report
  • September 2016
  • by Global Markets Direct

C-X-C Chemokine Receptor Type 1 (CDw128a or High Affinity Interleukin 8 Receptor A or IL8 Receptor Type 1 or CD181 or CXCR1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘C-X-C Chemokine ...

  • Industries : Therapy, Biological Therapy
  • Countries : United States, World
Atypical Chemokine Receptor 3 (C-X-C Chemokine Receptor Type 7 or Chemokine Orphan Receptor 1 or G Protein Coupled Receptor 159 or G Protein Coupled Receptor RDC1 Homolog or GPR159 or CXCR7 or ACKR3) - Pipeline Review, H2 2016

Atypical Chemokine Receptor 3 (C-X-C Chemokine Receptor Type 7 or Chemokine Orphan Receptor 1 or G Protein Coupled Receptor 159 or G Protein Coupled Receptor RDC1 Homolog or GPR159 or CXCR7 or ACKR3) - Pipeline Review, H2 2016

  • € 3182
  • Company report
  • September 2016
  • by Global Markets Direct

Atypical Chemokine Receptor 3 (C-X-C Chemokine Receptor Type 7 or Chemokine Orphan Receptor 1 or G Protein Coupled Receptor 159 or G Protein Coupled Receptor RDC1 Homolog or GPR159 or CXCR7 or ACKR3) - ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : World
Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) - Pipeline Review, H2 2016

Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) - Pipeline Review, H2 2016

  • € 3182
  • Company report
  • September 2016
  • by Global Markets Direct

Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 ...

  • Industries : Biopharmaceutical, Biological Therapy, Therapy, Biotechnology, Pathology
  • Countries : United States, World, Europe
C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1 Alpha Receptor or RANTES R or CD191 or CCR1) - Pipeline Review, H2 2016

C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1 Alpha Receptor or RANTES R or CD191 or CCR1) - Pipeline Review, H2 2016

  • € 3182
  • Company report
  • September 2016
  • by Global Markets Direct

C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1 Alpha Receptor or RANTES R or CD191 or CCR1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘C-C ...

  • Industries : Biological Therapy, Pathology, Drug Discovery and Development, Chronic Disease, Therapy, Biotechnology
  • Countries : United States
C-C Chemokine Receptor Type 3 (Eosinophil Eotaxin Receptor or CD193 or CCR3) - Pipeline Review, H2 2016

C-C Chemokine Receptor Type 3 (Eosinophil Eotaxin Receptor or CD193 or CCR3) - Pipeline Review, H2 2016

  • € 3182
  • Company report
  • September 2016
  • by Global Markets Direct

C-C Chemokine Receptor Type 3 (Eosinophil Eotaxin Receptor or CD193 or CCR3) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘C-C Chemokine Receptor Type 3 (Eosinophil Eotaxin Recepto ...

  • Industries : Chronic Disease, Biopharmaceutical, Biological Therapy, Pathology
  • Countries : World
Nicotinamide Phosphoribosyltransferase (Visfatin or Pre B Cell Colony Enhancing Factor 1 or NAMPT or EC 2.4.2.12) - Pipeline Review, H2 2016

Nicotinamide Phosphoribosyltransferase (Visfatin or Pre B Cell Colony Enhancing Factor 1 or NAMPT or EC 2.4.2.12) - Pipeline Review, H2 2016

  • € 3182
  • Company report
  • September 2016
  • by Global Markets Direct

Nicotinamide Phosphoribosyltransferase (Visfatin or Pre B Cell Colony Enhancing Factor 1 or NAMPT or EC 2.4.2.12) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Nicotinamide Phospho ...

  • Industries : Biological Therapy, Pathology, Therapy, Drug Discovery and Development, Cancer
  • Countries : United States, World
2016 Cell Surface Markers: Emerging Opportunities, Country Forecasts, Innovative Technologies, Competitive Landscape--US, Europe (France, Germany, Italy, Spain, UK), Japan

2016 Cell Surface Markers: Emerging Opportunities, Country Forecasts, Innovative Technologies, Competitive Landscape--US, Europe (France, Germany, Italy, Spain, UK), Japan

  • € 3182
  • Industry report
  • September 2016
  • by Venture Planning Group

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic ...

  • Industries : Biological Therapy
  • Countries : United States, Spain, France, Italy, United Kingdom, Japan
Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen 8 or CTLA8 or IL17A) - Pipeline Review, H2 2016

Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen 8 or CTLA8 or IL17A) - Pipeline Review, H2 2016

  • € 3182
  • Company report
  • September 2016
  • by Global Markets Direct

Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen 8 or CTLA8 or IL17A) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen ...

  • Industries : Pathology
  • Countries : United States
2016-2021  World Cell Surface Marker Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

2016-2021 World Cell Surface Marker Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

  • € 3182
  • Industry report
  • November 2016
  • by Venture Planning Group

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic ...

  • Industries : Biological Therapy
  • Countries : United States, Spain, France, Italy, United Kingdom, Japan
Interleukin 13 (IL13) - Pipeline Review, H2 2016

Interleukin 13 (IL13) - Pipeline Review, H2 2016

  • € 3182
  • Company report
  • October 2016
  • by Global Markets Direct

Interleukin 13 (IL13) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 13 (IL13) - Pipeline Review, H2 2016’, provides in depth analysis on Interleukin 13 (IL13) targeted ...

  • Industries : Pathology, Biopharmaceutical, Therapy, Chronic Disease, Biological Therapy, Biotechnology
  • Countries : United States
Human cytomegalovirus 65 kDa Phosphoprotein (PP65 or 65 kDa Matrix Phosphoprotein or Tegument Protein UL83 or UL83) - Pipeline Review, H2 2016

Human cytomegalovirus 65 kDa Phosphoprotein (PP65 or 65 kDa Matrix Phosphoprotein or Tegument Protein UL83 or UL83) - Pipeline Review, H2 2016

  • € 3182
  • Company report
  • October 2016
  • by Global Markets Direct

Human cytomegalovirus 65 kDa Phosphoprotein (PP65 or 65 kDa Matrix Phosphoprotein or Tegument Protein UL83 or UL83) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Human cytomegalovirus ...

  • Industries : Biopharmaceutical, Therapy, Biotechnology
  • Countries : World
Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Pipeline Review, H2 2016

Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Pipeline Review, H2 2016

  • € 3182
  • Company report
  • October 2016
  • by Global Markets Direct

Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Telomerase ...

  • Industries : Cancer, Pathology, Therapy, Biopharmaceutical, Biotechnology, Pharmaceutical
  • Countries : United States, World
C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H2 2016

C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H2 2016

  • € 3182
  • Company report
  • October 2016
  • by Global Markets Direct

C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion ...

  • Industries : Therapy, Biological Therapy, Pharmaceutical
  • Countries : United States, World
Programmed Cell Death 1 Ligand 1 (PD L1 or B7 Homolog 1 or CD274) - Pipeline Review, H2 2016

Programmed Cell Death 1 Ligand 1 (PD L1 or B7 Homolog 1 or CD274) - Pipeline Review, H2 2016

  • € 3182
  • Company report
  • October 2016
  • by Global Markets Direct

Programmed Cell Death 1 Ligand 1 (PD L1 or B7 Homolog 1 or CD274) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Programmed Cell Death 1 Ligand 1 (PD L1 or B7 Homolog 1 or CD274) - Pipeline ...

  • Industries : Cancer, Therapy, Pathology, Oncology
  • Countries : United States
C-X-C Chemokine Receptor Type 4 (FB22 or Fusin or HM89 or LCR1 or Leukocyte Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide Associated Protein 3 or Stromal Cell Derived Factor 1 Receptor or NPYRL or CD184 or CXCR4) - Pipeline Review, H2

C-X-C Chemokine Receptor Type 4 (FB22 or Fusin or HM89 or LCR1 or Leukocyte Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide Associated Protein 3 or Stromal Cell Derived Factor 1 Receptor or NPYRL or CD184 or CXCR4) - Pipeline Review, H2

  • € 3182
  • Company report
  • October 2016
  • by Global Markets Direct

C-X-C Chemokine Receptor Type 4 (FB22 or Fusin or HM89 or LCR1 or Leukocyte Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide Associated Protein 3 or Stromal Cell Derived Factor 1 Recepto ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States
Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) - Pipeline Review, H2 2016

Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) - Pipeline Review, H2 2016

  • € 3182
  • Company report
  • October 2016
  • by Global Markets Direct

Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Glial Cell Line Derived Neurotrophic Factor (Astrocyte ...

  • Industries : Mental Health, Pathology, Biological Therapy
  • Countries : World, Europe
Tumor Necrosis Factor Receptor Superfamily Member 5 (B Cell Surface Antigen CD40 or Bp50 or CDw40 or CD40L Receptor or TNFRSF5 or CD40) - Pipeline Review, H2 2016

Tumor Necrosis Factor Receptor Superfamily Member 5 (B Cell Surface Antigen CD40 or Bp50 or CDw40 or CD40L Receptor or TNFRSF5 or CD40) - Pipeline Review, H2 2016

  • € 3182
  • Company report
  • October 2016
  • by Global Markets Direct

Tumor Necrosis Factor Receptor Superfamily Member 5 (B Cell Surface Antigen CD40 or Bp50 or CDw40 or CD40L Receptor or TNFRSF5 or CD40) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Tumo ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology, Pathology, Therapy
  • Countries : United States
Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H2 2016

Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H2 2016

  • € 3182
  • Company report
  • October 2016
  • by Global Markets Direct

Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Cytotoxic T Lymphocyte Protein 4 (Cytotoxic ...

  • Industries : Biopharmaceutical, Biotechnology, Therapy, Cancer, Pathology, Biological Therapy
  • Countries : United States
Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H2 2016

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H2 2016

  • € 3182
  • Company report
  • October 2016
  • by Global Markets Direct

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) ...

  • Industries : Pathology, Biological Therapy, Therapy, Cancer
  • Countries : United States
Global and Chinese Stem Cell Therapy Industry, 2016 Market Research Report

Global and Chinese Stem Cell Therapy Industry, 2016 Market Research Report

  • € 2727
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese Stem Cell Therapy Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global Stem Cell Therapy industry with a focus ...

  • Industries : Biological Therapy
  • Countries : World
Global Stem Cell Partnering 2010-2016: Deal trends, players, financials and forecasts

Global Stem Cell Partnering 2010-2016: Deal trends, players, financials and forecasts

  • € 2723
  • Industry report
  • November 2016
  • by Currentpartnering

The Global Stem Cell Partnering 2010-2016: Deal trends, players, financials and forecasts report provides comprehensive understanding and unprecedented access to the stem cell partnering deals and agreements ...

  • Industries : Biological Therapy
  • Countries : World
Global Gene Therapy Partnering Terms and Agreements 2010 to 2016

Global Gene Therapy Partnering Terms and Agreements 2010 to 2016

  • € 2723
  • Industry report
  • October 2016
  • by Currentpartnering

The Global Gene Therapy Partnering Agreements 2010-2016 report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. ...

  • Industries : Biological Therapy, Pathology, Healthcare, Biotechnology, Therapy
  • Countries : United States
Global Stem Cell Therapies Market Research Report 2016

Global Stem Cell Therapies Market Research Report 2016

  • € 2591
  • Industry report
  • October 2016
  • by 9Dimen Research

2016 Global Stem Cell Therapies Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Stem Cell Therapies industry, focusing on the main ...

  • Industries : Biological Therapy
  • Countries : World, Europe, Asia, North America
About 2800 reports

Download Unlimited Documents from Trusted Public Sources

Medigene AG - Investor Report, December 2016

  • December 2016
    39 pages
  • Immunotherapy  

    Cell Therapy  

  • Germany  

View report >

Filgrastim Industry

December 2016

Microrna Industry

November 2016

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.